subject area of
- Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials Journal Articles
- Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice Journal Articles
- Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia Journal Articles
- Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies Journal Articles
- Regulation of plasminogen activator inhibitor-1 secretion by growth factors in smooth muscle cells Journal Articles
- Therapeutic Potential of Spleen Tyrosine Kinase Inhibition for Treating High-Risk Precursor B Cell Acute Lymphoblastic Leukemia Journal Articles
- β2 integrin–derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis Journal Articles